Amy R. Marks

Amy R. Marks

Auto-generated profile, based on publicly available information

Amy R. Marks

Division of Research Kaiser Permanente Northern California Oakland CA USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 April 2014 in New England Journal of Medicine
Verified
Journal Article
Closed access
DCDouglas A. Corley
Douglas A. Corley
CJChristopher D. Jensen
Christopher D. Jensen
AMAmy R. Marks
Amy R. Marks
WZWei K. Zhao
Wei K. Zhao
JLJeffrey K. Lee
Jeffrey K. Lee
CQCharles P. Quesenberry
Charles P. Quesenberry
To the Editor: The study by Corley and colleagues (April 3 issue)1 of the association between the adenoma detection rate of colonoscopists and the development of interval colorectal cancer has some noteworthy limitations. First, the central conclusion that the “risk of interval cancer decreased approximately linearly with increasing adenoma detection rates, without evidence of a threshold effect within the observed range of rates” was not supported by the study findings. The risk of interval cancer was in fact fairly uniform across the first three adenoma detection rate quintiles, even though the corresponding quintile subgroups included 11 times as many events . . .

1 May 2007 in Environmental Health Perspectives
Verified
Journal Article
Open access
BEBrenda Eskenazi
Brenda Eskenazi
AMAmy R. Marks
Amy R. Marks
ABAsa Bradman
Asa Bradman
KHKim Harley
Kim Harley
DBDana B. Barr
Dana B. Barr
NJNicholas P. Jewell
Nicholas P. Jewell
Background: Organophosphate (OP) pesticides are widely used in agriculture and homes. Animal studies suggest that even moderate doses are neurodevelopmental toxicants, but there are few studies in humans. Objectives: We investigated the relationship of prenatal and child OP urinary metabolite levels with children’s neurodevelopment. Methods: Participating children were from a longitudinal birth cohort of primarily Latino farm-worker families in California. We measured six nonspecific dialkylphosphate (DAP) metabolites in maternal and child urine as well as metabolites specific to malathion (MDA) and chlorpyrifos (TCPy) in maternal urine. We examined their association with children’s performance at 6 (n = 396), 12 (n = 395), and 24 (n = 372) months of age on the Bayley Scales of Infant Development [Mental Development (MDI) and Psychomotor Development (PDI) Indices] and mother’s report on the Child Behavior Checklist (CBCL) (n = 356). Results: Generally, pregnancy DAP levels were negatively associated with MDI, but child measures were positively associated. At 24 months of age, these associations reached statistical significance [per 10-fold increase in prenatal DAPs: β = −3.5 points; 95% confidence interval (CI), −6.6 to −0.5; child DAPs: β = 2.4 points; 95% CI, 0.5 to 4.2]. Neither prenatal nor child DAPs were associated with PDI or CBCL attention problems, but both prenatal and postnatal DAPs were associated with risk of pervasive developmental disorder [per 10-fold increase in prenatal DAPs: odds ratio (OR) = 2.3, p = 0.05; child DAPs OR = 1.7, p = 0.04]. MDA and TCPy were not associated with any outcome. Conclusions: We report adverse associations of prenatal DAPs with mental development and pervasive developmental problems at 24 months of age. Results should be interpreted with caution given the observed positive relationship with postnatal DAPs.

1 December 2010 in Environmental Health Perspectives
Verified
Journal Article
Open access
AMAmy R. Marks
Amy R. Marks
KHKim Harley
Kim Harley
ABAsa Bradman
Asa Bradman
KKKatherine Kogut
Katherine Kogut
DBDana Boyd Barr
Dana Boyd Barr
BEBrenda Eskenazi
Brenda Eskenazi
A peer-reviewed open access journal published by the National Institute of Environmental Health Sciences

1 April 2005 in Human Reproduction
Verified
Journal Article
Open access
PDF file
BEBrenda Eskenazi
Brenda Eskenazi
SKS.A. Kidd
S.A. Kidd
AMA.R. Marks
A.R. Marks
ESE. Sloter
E. Sloter
GBG. Block
G. Block
AWAndrew J Wyrobek
Andrew J Wyrobek
BACKGROUND: We seek to determine whether dietary and supplement intake of specific micronutrients (zinc and folate) and antioxidants (vitamins C, E and β-carotene) is associated with semen quality. METHODS: Ninety-seven healthy, non-smoking men provided semen and were interviewed. Average daily nutrient intake from food and supplements was derived from a self-administered food frequency questionnaire. Intake levels were summarized as low, moderate and high. Semen volume, sperm concentration, total sperm count, motility, progressive motility and total progressively motile sperm count (TPMS) were measured. RESULTS: After controlling for covariates, a high intake of antioxidants was associated with better semen quality but, in almost all cases, there was no clear dose relationship in that moderate intake groups had the poorest semen quality. For example, positive associations were observed between vitamin C intake and sperm number as reflected in the higher mean count (P=0.04), concentration (P=0.05) and TPMS (P=0.09); between vitamin E intake and progressive motility (P=0.04) and TPMS (P=0.05); and between β-carotene intake and sperm concentration (P=0.06) and progressive motility (P=0.06). Folate and zinc intake were not associated with improved semen quality. CONCLUSIONS: In a convenience sample of healthy non-smoking men from a non-clinical setting, higher antioxidant intake was associated with higher sperm numbers and motility.

1 May 2010 in Environmental Health Perspectives
Verified
Journal Article
Open access
KHKim G Harley
Kim G Harley
AMAmy R. Marks
Amy R. Marks
JCJonathan Chevrier
Jonathan Chevrier
ABAsa Bradman
Asa Bradman
ASAndreas Sjödin
Andreas Sjödin
BEBrenda Eskenazi
Brenda Eskenazi
A peer-reviewed open access journal published by the National Institute of Environmental Health Sciences

1 February 2013 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
DCDouglas A. Corley
Douglas A. Corley
CJChristopher D. Jensen
Christopher D. Jensen
AMAmy R. Marks
Amy R. Marks
WZWei K. Zhao
Wei K. Zhao
JBJolanda de Boer
Jolanda de Boer
CQCharles P. Quesenberry
Charles P. Quesenberry